FDA.reportPublic FDA data

NO-WEAK-NAILS

Manufacturer
Miers Laboratories
Effective date
2025-01-09
Label type
HUMAN OTC DRUG LABEL
Version
4
Source
full-release
Hydrated at
2026-06-01 02:30:26

Label at a glance#

ProductNO-WEAK-NAILS
Active ingredientGRAPHITE, THUJA OCCIDENTALIS LEAFY TWIG, SILICON DIOXIDE
Label structure9 sections

Indications and uses

Improves the strength and appearance of finger nails

Dosage and administration

Age Dose Adults and Children 2 years and over Chew two tablets four times a day for two days until all taken. Under 2 years Ask a doctor.

Storage and handling

Store under 86°F (30°C) No drug interactions Non-drowsy

Label contents#

Full prescribing information#

SPL UNCLASSIFIED SECTION

Drug Facts

Active Ingredients

OTC - ACTIVE INGREDIENT SECTION

Graphite 30C HPUS
Thuja Occi 30C HPUS
Silicon Dioxide 30C HPUS

The letters HPUS indicate that these ingredients are officially included in the Homeopathic Pharmacopeia of the United States.

Purpose

OTC - PURPOSE SECTION

To improve nails

Uses

INDICATIONS & USAGE SECTION

Improves the strength and appearance of finger nails

Warnings

WARNINGS SECTION

OTC - DO NOT USE SECTION

Do not use if the blister pack is broken.

OTC - ASK DOCTOR SECTION

Ask a doctor before use in children under 2 years of age.

OTC - STOP USE SECTION

Stop use and ask a doctor if symptoms persist for more than 3 days or worsen.

OTC - PREGNANCY OR BREAST FEEDING SECTION

If pregnant or breast-feeding, ask a health professional before use.

OTC - KEEP OUT OF REACH OF CHILDREN SECTION

Keep out of reach of children. In case of overdose, get medical help or contact a Poison Control Center right away.

Directions

DOSAGE & ADMINISTRATION SECTION

AgeDose
Adults and Children 2 years and overChew two tablets four times a day for two days until all taken.
Under 2 yearsAsk a doctor.

Other Information

STORAGE AND HANDLING SECTION

  • Store under 86°F (30°C)
  • No drug interactions
  • Non-drowsy

Inactive ingredients

INACTIVE INGREDIENT SECTION

Dextrose and separating agents magnesium stearate and silicon dioxide

PRINCIPAL DISPLAY PANEL - 16 Tablet Blister Pack Carton

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC 59672-0916-2

HOMEOPATHIC
WEAK NAILS PREVENTION

NO-WEAK-NAILS

Claims based on traditional homeopathic practice,
not accepted medical evidence. Not FDA evaluated

Net 16 Tablets

Principal Display Panel - 16 Tablet Blister Pack Carton
Principal Display Panel - 16 Tablet Blister Pack Carton

FDA-Initiated Inactive NDC Indexing#

NDC, Effective, Action table
NDCEffectiveActionDocumentIndexing SPLRelated label
59672-0916-12023-12-14C16284748780-19d75b9cf-f01a-f424-e053-dadaa90a57ceNO-WEAK-NAILS
59672-0916-12020-01-31C16284748780-19d75b9cf-f01a-f424-e053-dadaa90a57ceNO-WEAK-NAILS

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59672-0916-2NO-WEAK-NAILS1 in 1 CARTONTABLET14
59672-0916-2NO-WEAK-NAILS16 in 1 BLISTER PACKTABLET164

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59672-0916NO-WEAK-NAILS (GRAPHITE, THUJA OCCIDENTALIS LEAFY TWIG, AND SILICON DIOXIDE) TABLET [MIERS LABORATORIES]4Current NDC, Legacy NDC, 2 package rows20250112_9158cd3f-4c27-40e9-bc07-fd560375c3a1.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
GRAPHITEACTIVE INGREDIENT4QQN74LH4O1
SILICON DIOXIDEACTIVE INGREDIENTETJ7Z6XBU41
THUJA OCCIDENTALIS LEAFY TWIGACTIVE INGREDIENT1NT28V93971
GRAPHITEACTIVE MOIETY4QQN74LH4O1
SILICON DIOXIDEACTIVE MOIETYETJ7Z6XBU41
THUJA OCCIDENTALIS LEAFY TWIGACTIVE MOIETY1NT28V93971
DextroseINACTIVE INGREDIENTIY9XDZ35W21
Magnesium stearateINACTIVE INGREDIENT70097M6I301

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 7 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
59672-091659672-0916-2

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Name, UNII, Kind table
NameUNIIKind
GRAPHITE4QQN74LH4OACTIB
THUJA OCCIDENTALIS LEAFY TWIG1NT28V9397ACTIB
SILICON DIOXIDEETJ7Z6XBU4ACTIB
DEXTROSE, UNSPECIFIED FORMIY9XDZ35W2IACT
Magnesium stearate70097M6I30IACT

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 1 · 4 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
Magnesium stearateMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
DextroseDEXTROSEIY9XDZ35W2TABLET / ORAL183.66 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
Magnesium stearateMAGNESIUM STEARATE70097M6I30TABLET / ORAL980 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates
DextroseDEXTROSEIY9XDZ35W2TABLET / ORAL183.66 mgExact identifier — unii+route+dosage form
2 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
NO-WEAK-NAILSGRAPHITE, THUJA OCCIDENTALIS LEAFY TWIG, AND SILICON DIOXIDEMiers Laboratories9158cd3f-4c27-40e9-bc07-fd560375c3a12025-01-09WarningsExact identifier
ndc (package): 59672-0916-2
ndc (product): 59672-0916
ndc11 (package): 59672091602
spl id: 602d950e-0b4e-4be0-a84d-f459bd0c9aa3
spl set id: 9158cd3f-4c27-40e9-bc07-fd560375c3a1

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.